ArticlePharmaceuticals (Basel, Switzerland)2025

Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Bojana Milašinović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.